Clinical Operations Journal by Dx Direct

Respiratory Diagnostics

Why Respiratory Season Feels Like a Losing Battle for Clinicians

Every year, respiratory season arrives with a familiar sense of urgency. Waiting rooms fill up, schedules become overloaded, and clinicians find themselves managing an endless stream of patients with nearly identical symptoms. A patient comes in with a fever, cough, sore throat, congestion, fatigue, or body aches. Ten minutes later, another patient presents with the same complaints. Then another. And another. For healthcare providers, respiratory season is more than just a busy time of year—it’s often one of the most challenging periods for delivering efficient, high-quality care. The difficulty isn’t

Read More »
Antibiotic Stewardship

Bacterial or Non-Bacterial? How to Get Better Clinical Answers Before the Patient Leaves the Room

One of the biggest challenges in outpatient medicine is making fast, accurate treatment decisions when symptoms are unclear. A patient walks into urgent care with: fever sore throat fatigue congestion cough Clinically, the presentation may suggest an infection—but determining whether it’s bacterial or non-bacterial isn’t always straightforward during the initial visit. That uncertainty affects everything from antibiotic prescribing to patient expectations and follow-up planning. In busy clinics where time matters, providers increasingly need diagnostic support that can help guide decisions before the patient leaves the room. Why It’s Often Difficult

Read More »
Point-of-Care Testing (POCT)

FebriDx Just Got a CLIA Waiver, Here’s What That Means for Your Clinic

Point-of-care tests are evolving quickly and that’s great news! In primary care clinics, urgent care centers and outpatient departments, there’s always a need to balance quick testing and accuracy. If you’ve ever seen a patient with symptoms like fever, sore throat, or cough, you know that you have to find answers for two questions: what’s wrong and how soon we can figure it out. The recent CLIA waiver for FebriDx is a meaningful step forward. It signals that this rapid test can now be used more broadly in clinical settings

Read More »
Antibiotic Stewardship

Why Distinguishing Viral vs. Bacterial Infections Remains a Challenge in Urgent Care

Distinguishing between viral and bacterial infections remains one of the most common diagnostic challenges in primary care and urgent care settings. Patients frequently present with similar symptoms regardless of the underlying cause, making accurate diagnosis difficult during a single clinical encounter. This challenge is amplified by time constraints, patient expectations, and the limitations of symptom-based evaluation. Overlapping Clinical Symptoms Viral and bacterial infections often share the same clinical presentation, particularly in respiratory illnesses. Symptoms such as fever, cough, sore throat, fatigue, and body aches are common to both. In early

Read More »
Dx Direct

FDA Approved vs. FDA Cleared: Understanding the Key Difference You Need to Know

In recent years, advanced consumer technology has rapidly evolved to include health-monitoring features, from fitness trackers to wearable devices. As these products gain popularity, more and more tech companies are seeking FDA approval or clearance to market their devices. But here’s the catch: FDA approval and FDA clearance aren’t the same thing. Knowing the difference can be crucial to understanding the safety and effectiveness of the devices you’re using. Let’s break it down. What Does the FDA Do? The Food and Drug Administration (FDA) is responsible for ensuring that foods, drugs, and

Read More »

Simplifying Point-of-Care Adoption

Supporting better decisions without adding complexity.

FebriDx is intended to support clinical decision-making and must be interpreted in the context of signs, symptoms, patient history, and clinical judgment. It does not identify a specific pathogen and is not a standalone diagnostic.

FebriDx® is manufactured by Lumos Diagnostics. Dx Direct serves as an authorized distribution channel and does not manufacture the product.

© 2026. All Rights Reserved.